TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
2.480
0.00 (0.00%)
At close: Oct 17, 2025, 4:00 PM EDT
2.450
-0.030 (-1.21%)
After-hours: Oct 17, 2025, 7:38 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $140.74 million as of October 17, 2025. Its market cap has decreased by -46.65% in one year.
Market Cap
140.74M
Enterprise Value
19.39M
1-Year Change
-46.65%
Ranking
Category
Stock Price
$2.48
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $140.74M, a decrease of -60.81%. That is a compound annual growth rate of -19.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 140.74M | -18.07% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.27B |
| Johnson & Johnson | 461.34B |
| AbbVie | 401.10B |
| UnitedHealth Group | 327.38B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 224.19B |